NCT06007950

Brief Summary

The goal of this clinical trial is to learn about the effects of time-restricted eating in patients with history of acute coronary syndrome. The main questions it aims to answer are: 1) Is 10-hr TRE safe and feasible for patients with ACS; 2)What are the impacts of 10-hr TRE on anthropometric measurements, cardiometabolic health and cardiovascular health compared to ad libitum eating in patients with ACS?. Participants will be asked to limit eating duration to 10 hours daily.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 11, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

August 23, 2023

Completed
9 days until next milestone

Study Start

First participant enrolled

September 1, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

July 18, 2024

Status Verified

July 1, 2024

Enrollment Period

1 year

First QC Date

August 11, 2023

Last Update Submit

July 17, 2024

Conditions

Keywords

coronary heart diseasetime-restricted eatingintermittent fasting

Outcome Measures

Primary Outcomes (1)

  • Change in weight

    unit: kg

    4 weeks (pre- & post intervention)

Secondary Outcomes (17)

  • Change in lean body mass

    4 weeks (pre- & post intervention)

  • Change in fat mass

    4 weeks (pre- & post intervention)

  • Change in fasting glucose concentration

    4 weeks (pre- & post intervention)

  • Change in fasting insulin concentration

    4 weeks (pre- & post intervention)

  • Change in total cholesterol concentration

    4 weeks (pre- & post intervention)

  • +12 more secondary outcomes

Other Outcomes (2)

  • Rate of weekly compliance to intervention

    4 weeks

  • Change in caloric intake

    4 weeks (pre- & post intervention)

Study Arms (2)

Ad-libitum eating duration

NO INTERVENTION

24 patients will be randomly assigned to the control group. Participants will be asked to continue usual eating duration. Participants will receive the standard care and heart-healthy nutrition education.

Time-restricted eating (TRE) duration

EXPERIMENTAL

24 patients will be randomly assigned to the intervention group. Participants in this arm will be asked to limit the number of hours they eat in a day to 10 hours in addition to receiving the standard of care health and heart-healthy nutrition education.

Behavioral: Time-restricted eating 10-hr

Interventions

Time-restricted eating is a form of intermittent fasting. In this study, 10-hr TRE will be employed, where eating duration is limited to 10 hours. Participants are allowed to consume non-caloric beverages during fasting period.

Time-restricted eating (TRE) duration

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult, 18- 65 years old.
  • Had history of acute coronary syndrome (ACS)
  • Clinically stable
  • Self-reported eating window of at least 12 h per day.

You may not qualify if:

  • Severe obesity (body mass index ≥40 kg m-2).
  • Unstable weight in the past three months (gain or lose more than 4 kg of weight).
  • Unstable cardiovascular, renal, cardiac, liver, lung, adrenal, or nervous system disease that may compromise study validity.
  • Any medications or supplements known to change sleep, circadian rhythms, or metabolism.
  • Pregnant or lactating women.
  • Perform overnight shift work more than one day/week on average.
  • Regularly fasted for more than 15 hours/day or having completed twelve 24-hr fasts within the past three months).
  • Active use of tobacco or illicit drug or history of treatment for alcohol abuse.
  • Type I diabetes or diabetic, treated with insulin.
  • Use of anti-obesity drugs or other drugs affecting body weight.
  • Currently enrolled in weight loss or management programme, including surgical intervention.
  • Severe kidney failure (glomerular filtration rate (GFR) \<30 mL/min).
  • Eating disorder or current diagnosis of uncontrolled psychiatric illness, which may impair study involvement.
  • Malignancy undergoing active treatment.
  • Had gastrointestinal surgery or impaired nutrient absorption.
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pusat Perkhidmatan Klinikal (CTC) UiTM

Kuala Selangor, Malaysia

RECRUITING

MeSH Terms

Conditions

Myocardial InfarctionCoronary DiseaseIntermittent Fasting

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosisFastingFeeding BehaviorBehavior

Study Officials

  • Mazuin Kamarul Zaman, MMed Sc

    Universiti Teknologi Mara

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mazuin Kamarul Zaman, MMed Sc

CONTACT

Nur Islami Mohd Fahmi Teng, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 11, 2023

First Posted

August 23, 2023

Study Start

September 1, 2023

Primary Completion

September 1, 2024

Study Completion

September 1, 2025

Last Updated

July 18, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations